Copper bis(4-(1,3-benzothiazol-2-yl)-2-methoxy-6-[[methyl(pyridin-2-ylmethyl)amino]methyl]phenolate)
C44H40CuN6O4S2 — CID 139121066
Data last refreshed: (MolForge compound catalog, from PubChem)
About Copper bis(4-(1,3-benzothiazol-2-yl)-2-methoxy-6-[[methyl(pyridin-2-ylmethyl)amino]methyl]phenolate)
Copper bis(4-(1,3-benzothiazol-2-yl)-2-methoxy-6-[[methyl(pyridin-2-ylmethyl)amino]methyl]phenolate) (PubChem CID 139121066) has the molecular formula C44H40CuN6O4S2 and a molecular weight of 844.52 g/mol. Its IUPAC name is copper bis(4-(1,3-benzothiazol-2-yl)-2-methoxy-6-[[methyl(pyridin-2-ylmethyl)amino]methyl]phenolate).
Molecular Properties
| Compound Name | Copper bis(4-(1,3-benzothiazol-2-yl)-2-methoxy-6-[[methyl(pyridin-2-ylmethyl)amino]methyl]phenolate) |
|---|---|
| PubChem CID | 139121066 |
| Molecular Formula | C44H40CuN6O4S2 |
| Molecular Weight | 844.52 g/mol |
| Exact Mass | 843.18 |
| IUPAC Name | copper bis(4-(1,3-benzothiazol-2-yl)-2-methoxy-6-[[methyl(pyridin-2-ylmethyl)amino]methyl]phenolate) |
| SMILES | COc1cc(-c2nc3ccccc3s2)cc(CN(C)Cc2ccccn2)c1[O-].COc1cc(-c2nc3ccccc3s2)cc(CN(C)Cc2ccccn2)c1[O-].[Cu+2] |
| InChI | InChI=1S/2C22H21N3O2S.Cu/c2*1-25(14-17-7-5-6-10-23-17)13-16-11-15(12-19(27-2)21(16)26)22-24-18-8-3-4-9-20(18)28-22;/h2*3-12,26H,13-14H2,1-2H3;/q;;+2/p-2 |
| InChIKey | MCEIGWQQZDDKGS-UHFFFAOYSA-L |
| XLogP | 8.14 |
| TPSA | 122.62 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 12 |
| Rotatable Bonds | 12 |
| Heavy Atoms | 57 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 844.52 |
| LogP ≤ 5 | 8.14 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 12 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 139121066 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.